Abstract
Chronic intermittent hypoxia (CIH) is a major contributor to the development of hypertension (HTN) in obstructive sleep apnea (OSA). OSA subjects frequently display a non-dipping pattern of blood pressure (BP) and resistant HTN. After discovering that AHR-CYP1A1 axis is a druggable target in CIH-HTN, we hypothesized that CH-223191 could control BP in both active and inactive periods of the animals, recovering the BP dipping profile in CIH conditions.
We evaluated the chronopharmacology of the antihypertensive efficacy of the AhR blocker CH-223191 in CIH conditions (21% to 5% of O2, 5.6 cycles/h, 10.5 h/day, in inactive period of Wistar rats). BP was measured by radiotelemetry, at 8 am (active phase) and at 6 pm (inactive phase) of the animals. The circadian variation of AhR activation in the kidney in normoxia was also assessed, measuring the CYP1A1 (hallmark of AhR activation) protein levels.
Despite drug administration before starting the inactive period of the animals, CH-223191 was not able to decrease BP during the inactive phase, in CIH conditions, therefore not reverting the non-dipping profile. These results suggest that a higher dose or different time of administration of CH-223191 might be needed for an antihypertensive effect throughout the 24-h cycle.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adamovich Y et al (2017) Rhythmic oxygen levels reset Circadian clocks through HIF1α. Cell Metab 25(1):93–101. https://doi.org/10.1016/j.cmet.2016.09.014
Baker J, Kimpinski K (2018) Role of melatonin in blood pressure regulation: an adjunct anti-hypertensive agent. Clin Exp Pharmacol Physiol 45(8):755–766. https://doi.org/10.1111/1440-1681.12942
Coelho NR et al (2020) First evidence of aryl hydrocarbon receptor as a druggable target in hypertension induced by chronic intermittent hypoxia. Pharmacol Res 159:104869. https://doi.org/10.1016/j.phrs.2020.104869
Coelho NR et al (2021) AHR canonical pathway: in vivo findings to support novel antihypertensive strategies. Pharmacol Res 165:105407. https://doi.org/10.1016/j.phrs.2020.105407
Coelho NR et al (2022) Pharmacological blockage of the AHR-CYP1A1 axis: a call for in vivo evidence. J Mol Med 100(2):215–243. https://doi.org/10.1007/s00109-021-02163-2
Correia MJ et al (2021) Aryl hydrocarbon receptor and cysteine redox dynamics underlie (Mal)adaptive mechanisms to chronic intermittent hypoxia in kidney cortex. Antioxidants 10(9):1484. https://doi.org/10.3390/antiox10091484
Diogo LN et al (2015) The association between antihypertensive medication and blood pressure control in patients with obstructive sleep apnea, pp. 201–209. https://doi.org/10.1007/978-3-319-18440-1_22
Emans TW et al (2017) Circadian rhythm in kidney tissue oxygenation in the rat. Front Physiol 8. https://doi.org/10.3389/fphys.2017.00205
Gentner NJ, Weber LP (2011) Intranasal benzo[a]pyrene alters circadian blood pressure patterns and causes lung inflammation in rats. Arch Toxicol 85(4):337–346. https://doi.org/10.1007/s00204-010-0589-6
Gumz ML (2016) Molecular basis of circadian rhythmicity in renal physiology and pathophysiology. Exp Physiol 101(8):1025–1029. https://doi.org/10.1113/EP085781
Jaeger C, Tischkau SA (2016) Role of aryl hydrocarbon receptor in circadian clock disruption and metabolic dysfunction. Environ Health Insights 10:EHI.S38343. https://doi.org/10.4137/EHI.S38343
Lu J et al (2020) New insights of CYP1A in endogenous metabolism: a focus on single nucleotide polymorphisms and diseases. Acta Pharm Sin B 10(1):91–104. https://doi.org/10.1016/j.apsb.2019.11.016
Mähler (Convenor) M et al (2014) FELASA recommendations for the health monitoring of mouse, rat, hamster, guinea pig and rabbit colonies in breeding and experimental units. Lab Anim 48(3):178–192. https://doi.org/10.1177/0023677213516312
Marrone O, Bonsignore MR (2018) Blood-pressure variability in patients with obstructive sleep apnea: current perspectives. Nature Sci Sleep 10:229–242. https://doi.org/10.2147/NSS.S148543
Solocinski K, Gumz ML (2015) The Circadian clock in the regulation of renal rhythms. J Biol Rhythm 30(6):470–486. https://doi.org/10.1177/0748730415610879
Takahashi JS (2017) Transcriptional architecture of the mammalian circadian clock. Nat Rev Genet 18(3):164–179. https://doi.org/10.1038/nrg.2016.150
Tanimura N et al (2011) Aryl hydrocarbon receptor-mediated Cyp1a1 expression is modulated in a CLOCK-dependent circadian manner. Toxicology 290(2–3):203–207. https://doi.org/10.1016/j.tox.2011.09.007
Tischkau SA, Jaeger CD, Krager SL (2011) Circadian clock disruption in the mouse ovary in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Lett 201(2):116–122. https://doi.org/10.1016/j.toxlet.2010.12.013
Vorrink SU, Domann FE (2014) Regulatory crosstalk and interference between the xenobiotic and hypoxia sensing pathways at the AhR-ARNT-HIF1α signaling node. Chem Biol Interact 218:82–88. https://doi.org/10.1016/j.cbi.2014.05.001
Xu C-X et al (2013) Aryl hydrocarbon receptor activation attenuates Per1 gene induction and influences circadian clock resetting. Toxicol Sci 132(2):368–378. https://doi.org/10.1093/toxsci/kfs345
Acknowledgments
This work was supported by Fundação para Ciência e Tecnologia [PTDC/MED-TOX/30418/2017] and iNOVA4Health [UID/Multi/04462/2013]. A.B.P., M.J.C., and N.R.C. are supported by FCT grants [2022.11188.BD, SFRH/BD/131331/2017, and PD/BD/114257/2016, respectively].
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this paper
Cite this paper
Pimpão, A.B. et al. (2023). Control of Arterial Hypertension by the AhR Blocker CH-223191: A Chronopharmacological Study in Chronic Intermittent Hypoxia Conditions. In: Conde, S.V., Iturriaga, R., del Rio, R., Gauda, E., Monteiro, E.C. (eds) Arterial Chemoreceptors. ISAC XXI 2022. Advances in Experimental Medicine and Biology, vol 1427. Springer, Cham. https://doi.org/10.1007/978-3-031-32371-3_4
Download citation
DOI: https://doi.org/10.1007/978-3-031-32371-3_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-32370-6
Online ISBN: 978-3-031-32371-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)